Home/ Applications/ Malaria & Tropical Disease Research
SeamlessBio — Solutions by Application

Malaria & Tropical Disease Research — Human Serum AB for Plasmodium falciparum Culture

Plasmodium falciparum in vitro culture is the cornerstone of malaria drug discovery, vaccine development, and parasite biology research. The Trager and Jensen protocol (1976) established human red blood cells and human serum as the required culture components — and this remains the standard today. SeamlessBio supplies Human Serum Type AB OTC for Plasmodium culture and Human Serum AB Heat Inactivated for PBMC-based immunological assays.

Why Type AB serum is required for Plasmodium culture: Plasmodium falciparum infects and replicates within human red blood cells. Anti-A and anti-B antibodies present in non-AB serum types cause agglutination and haemolysis of RBCs used in culture — destroying the host cells needed for parasite replication. Type AB serum contains no anti-A or anti-B antibodies and is the only blood group compatible with mixed RBC preparations from any donor.
01

Human Serum AB OTC — Plasmodium Culture

The published standard (Trager & Jensen 1976) for continuous P. falciparum culture. AB type — no RBC agglutination. Native OTC — complement intact for natural growth conditions. 5% in RPMI-1640.

02

Human Serum AB HI — PBMC Assays

For PBMC-based malaria immunology: ELISpot, cytokine assays, proliferation. Heat inactivated (56°C/30 min) eliminates complement-mediated PBMC lysis during antigen stimulation.

03

BSA Low Endotoxin — AlbuMAX Alternative

BSA Low Endotoxin as base for AlbuMAX-equivalent serum-free P. falciparum culture. Used with lipid supplement at 0.5% equivalent concentration for defined conditions.

04

Lot Reservation — Full Campaign Coverage

Sorbitol synchronisation of P. falciparum requires 4–8 weeks of continuous culture in the same serum lot. SeamlessBio reserves dedicated lots for malaria research at no cost during the evaluation phase.

AlbuMAX vs Human Serum AB — when to use which

AlbuMAX (lipid-enriched BSA) supports P. falciparum growth and is used when defined serum-free conditions are required. However, Human Serum AB OTC remains the gold standard for parasitological assays where physiological serum conditions are important.

For drug susceptibility testing (DISA, RSA), Human Serum AB OTC is specifically required: human serum protein binding of antimalarial compounds (chloroquine, artemisinin, lumefantrine) is physiologically relevant. AlbuMAX underestimates protein binding and overestimates free drug concentration — leading to systematic errors in IC50 determination.

For routine passaging where defined conditions are acceptable and cost is the primary constraint, AlbuMAX provides lower lot-to-lot variability at lower cost. For assays that generate data for regulatory submissions or publication, Human Serum AB OTC is the appropriate choice.

Lot reservation is essential for malaria research: P. falciparum synchronisation by sorbitol requires 4–8 weeks of continuous culture. A serum lot change mid-synchronisation disrupts parasite growth kinetics, invalidates synchrony, and requires restarting from frozen stocks. SeamlessBio holds reserved lots at no cost during the evaluation phase.

Recommended products

Standard Protocol — Plasmodium falciparum Continuous Culture

ParameterSpecification
Base mediumRPMI-1640 + 25 mM HEPES + 0.2% NaHCO₃
Serum supplement5% Human Serum Type AB OTC (Trager & Jensen standard)
RBC sourceType O+ human erythrocytes — 2–5% haematocrit
Atmosphere5% CO₂ / 5% O₂ / 90% N₂ (candle jar or controlled gas mixture)
Temperature37°C
Serum alternativeAlbuMAX I or II (lipid-rich BSA) — serum-free option for defined conditions

Full Application Portfolio — Malaria & Tropical Disease Research

ApplicationRecommended ProductProtocol Note
P. falciparum continuous cultureHuman Serum AB OTC native — 5%Trager & Jensen protocol. Native complement intact. AB type — no RBC lysis.
Drug susceptibility assay (RSA, DISA)Human Serum AB OTC — 5%Human serum protein binding of antimalarials is physiologically relevant. AlbuMAX overestimates free drug.
PBMC stimulation — malaria antigensHuman Serum AB HI — 5–10%HI eliminates complement-mediated PBMC lysis during antigen stimulation.
IFN-γ ELISpot — vaccine immunogenicityHuman Serum AB HI or FBS VLE ≤1 EU/mLHuman Serum AB HI provides species-matched matrix for T cell responses to malaria antigens (RTS,S, R21).
Opsonophagocytosis (OPKA)Human Serum AB OTC native — 10–25%Active human complement required. Human IgG + complement for physiological opsonisation of P. falciparum-infected RBCs.
Leishmania / Trypanosoma cultureFBS Low Endotoxin ≤5 EU/mL — 10–20%SDM-79 (Leishmania), HMI-9 (Trypanosoma). Low Endotoxin reduces non-specific innate immune activation.
Toxoplasma gondii infection assayFBS Low Endotoxin ≤5 EU/mL — 10%HFF or Vero host cells. Low Endotoxin reduces background cytokine in macrophage infection models.
Complement fixation test (CFT)Guinea Pig SerumStandard complement source for tropical disease serology — Brucella, Leishmania, Trypanosoma CFT diagnostics.

Human Serum AB OTC vs AlbuMAX — Comparison

ParameterHuman Serum AB OTCAlbuMAX I/II
Physiological relevance✅ Native human serum — closest to in vivo conditionsLipid-enriched BSA — defined but non-physiological
Drug susceptibility testing✅ Correct protein binding of antimalarialsOverestimates free drug — underestimates protein binding
Lot-to-lot variabilityPooled donors — batch reservation minimises impactLower variability — defined composition
Complement activityActive — relevant for some invasion and OPKA assaysNo complement activity
CostHigherLower for routine passaging
Published standard✅ Trager & Jensen 1976 — WHO malaria reference protocolAlternative — widely used for routine passaging

Frequently Asked Questions

Why must serum be Type AB for Plasmodium falciparum culture?
P. falciparum replicates inside human red blood cells. Anti-A and anti-B antibodies present in Type A, B or O serum cause agglutination and haemolysis of the erythrocytes used as host cells — destroying the substrate for parasite replication. Type AB serum contains neither anti-A nor anti-B antibodies and is therefore compatible with RBC preparations from any blood group donor. This is the universal standard for P. falciparum continuous culture.
Should native (OTC) or heat inactivated serum be used for Plasmodium culture?
Native off-the-clot serum is standard for continuous P. falciparum culture and drug susceptibility assays — complement activity in native serum does not prevent parasite growth under standard culture conditions. Heat inactivated serum is used for PBMC-based immunological assays (ELISpot, proliferation, cytokine assays) where complement-mediated lysis of activated immune cells must be prevented.
Is Human Serum AB available from EU donors?
Yes — SeamlessBio supplies Human Serum Type AB OTC from EU-certified blood donor centres with full viral testing documentation (HIV, HBV, HCV, CMV, EBV, Parvovirus B19). EU and US origin both available. All lots include CoA, CoO and viral testing panel. Batch reservation available for extended malaria research programmes.
How much serum do I need for a 12-month malaria research programme?
A standard P. falciparum culture in 25 cm² flasks at 10 mL per flask, with medium changes every 48 hours and 5% serum, requires approximately 90 mL of Human Serum AB OTC per flask per month. For 4–6 flasks running continuously, plan for 500–600 mL per month — approximately 6–7 L per year. SeamlessBio recommends reserving 12 months' supply from a single lot to avoid synchrony disruption from lot changes.

Lot Reservation for Malaria Research Programmes

Human Serum AB OTC lot reservation — 6-week no-cost hold. Viral testing documentation (HIV, HBV, HCV, CMV, EBV, PVB19) per lot on request.
Email: info@seamlessbio.de | +49 851 37932226

Need a Lot Reservation or Test Sample?

Reserve your validated FBS or human serum lot — no prepayment.
Free test samples on request.

Name
+49 851 xxxx
How did you find us?